Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
Morgan H. James, Gary Aston‐Jones
Biological Psychiatry (2022) Vol. 92, Iss. 11, pp. 836-844
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
S P H Alexander, Arthur Christopoulos, Anthony P. Davenport, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. S2
Open Access | Times Cited: 219
Whole brain mapping of orexin receptor mRNA expression visualized by branchedin situhybridization chain reaction
Yousuke Tsuneoka, Hiromasa Funato
eNeuro (2024) Vol. 11, Iss. 2, pp. ENEURO.0474-23.2024
Open Access | Times Cited: 10
Binge eating, overeating and food addiction: Approaches for examining food overconsumption in laboratory rodents
Robyn M. Brown, Morgan H. James
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 123, pp. 110717-110717
Open Access | Times Cited: 19
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Identifying novel gene dysregulation associated with opioid overdose death: A meta-analysis of differential gene expression in human prefrontal cortex
Javan K. Carter, Bryan C. Quach, Caryn Willis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Sleep Loss and Substance Use Disorders: An Issue from Adolescents to Adults
Ana Clementina Equihua-Benítez, Rodolfo Espinoza-Abad, Fabio Garcı́a-Garcı́a
Behavioral Sciences (2025) Vol. 15, Iss. 2, pp. 220-220
Open Access
A Preliminary Report on the Effects of Daridorexant in Patients with Comorbid Insomnia and Substance Use Disorders
Marco Di Nicola, Maria Pepe, Lorenzo Bonomo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 378-378
Open Access
Awakening Sleep Medicine: The Transformative Role of Artificial Intelligence in Sleep Health
Arjun Bhatt, Suparna Sengupta, Ali Abolhassani, et al.
Current Sleep Medicine Reports (2025) Vol. 11, Iss. 1
Closed Access
Drugs of abuse drive neurotransmitter plasticity that alters behavior: implications for mental health
Marta Pratelli, Nicholas C. Spitzer
Frontiers in Behavioral Neuroscience (2025) Vol. 19
Open Access
Chronic but not acute morphine exposure reversibly impairs spike generation and repetitive firing in a functionally distinct subpopulation of orexin neurons
Emma Berry, Ellen N. Huhulea, Masaru Ishibashi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Most dynorphin neurons in the zona incerta-perifornical area are active in waking relative to non-rapid-eye movement and rapid-eye movement sleep
Priyattam J. Shiromani, Aurelio Vidal-Ortiz
SLEEP (2024) Vol. 47, Iss. 5
Open Access | Times Cited: 3
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Subpopulations of hypocretin/orexin neurons differ in measures of their cell proliferation, dynorphin co-expression, projections, and response to embryonic ethanol exposure
Nushrat Yasmin, Adam D. Collier, Olga Karatayev, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
The role of orexin-1 receptors within the ventral tegmental area in the extinction and reinstatement of methamphetamine place preference
Ferdos Zamanirad, Mojdeh Fattahi, Haleh Amirteymori, et al.
Behavioural Brain Research (2023) Vol. 453, pp. 114608-114608
Closed Access | Times Cited: 8
Evaluating the efficacy of the selective orexin 1 receptor antagonist nivasorexant in an animal model of binge‐eating disorder
Michel A. Steiner, Luca Botticelli, Giorgio Bergamini, et al.
International Journal of Eating Disorders (2024) Vol. 57, Iss. 7, pp. 1418-1432
Open Access | Times Cited: 2
Insomnia and the Orexinergic Pathway in the Link with Psychopathology: Effects of DORAs in Insomnia Comorbid with Mental Disturbances
Laura Palagini, Pierre A. Geoffroy, Gaspare Alfì, et al.
Current Sleep Medicine Reports (2024) Vol. 10, Iss. 2, pp. 119-131
Closed Access | Times Cited: 2
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
Taro Kishi, Michinori Koebis, Michiko SUGAWARA, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Cellular Localization of Orexin 1 Receptor in Human Hypothalamus and Morphological Analysis of Neurons Expressing the Receptor
Konstantina Vraka, D. Mytilinaios, Andreas P. Katsenos, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 592-592
Open Access | Times Cited: 5
Effects of methamphetamine on actigraphy-based sleep parameters in female rhesus monkeys: Orexin receptor mechanisms
Daniel Borgatti, James K. Rowlett, Laís F. Berro
Drug and Alcohol Dependence (2024) Vol. 259, pp. 111285-111285
Closed Access | Times Cited: 1
Machine Learning Models to Predict Ligand Binding Affinity for the Orexin 1 Receptor
Vanessa Zhang, Shayna L. O’Connor, William J. Welsh, et al.
Artificial Intelligence Chemistry (2023) Vol. 2, Iss. 1, pp. 100040-100040
Open Access | Times Cited: 4
Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder
Augustus M White, Michelle Eglovitch, Anna Beth Parlier‐Ahmad, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0304461-e0304461
Open Access | Times Cited: 1
The mechanism of different orexin/hypocretin neuronal projections in wakefulness and sleep
Nanxi Li, Lishan Huang, Bin Zhang, et al.
Brain Research (2024), pp. 149408-149408
Open Access | Times Cited: 1
Emerging medications and pharmacological treatment approaches for substance use disorders
Joel S. Raymond, Anastasios Athanasopoulos, Connie J. Badolato, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 248, pp. 173952-173952
Open Access | Times Cited: 1
The orexin neurotransmitter system as a target for medication development for opioid use disorder
Andrew S. Huhn, Kyla Dunn
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 329-330
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top